GAUCHER DISEASE

Course overview

GAUCHER DISEASE, THE MOST PREVALENT LYSOSOMAL STORAGE DISORDER, PRESENTS WITH AN ELEVATED INCIDENCE AMONG ASHKENAZI JEWS. IT IS AN AUTOSOMAL RECESSIVE INBORN ERROR OF METABOLISM CHARACTERIZED BY THE TOXIC ACCUMULATION OF GLUCOCEREBROSIDE LIPIDS WITHIN MULTIPLE ORGANS. GAUCHER DISEASE RESULTS FROM MUTATIONS IN THE GBA1 GENE, LEADING TO DEFICIENT GLUCOCEREBROSIDASE ACTIVITY WITHIN LYSOSOMES. CLINICAL MANIFESTATIONS, INCLUDING HEPATOSPLENOMEGALY, PANCYTOPENIA, OSTEOPOROSIS, AND AVASCULAR NECROSIS, VARY IN SEVERITY DEPENDING ON THE DISEASE TYPE. THIS ACTIVITY COMPREHENSIVELY EXAMINES THE ASSESSMENT AND MANAGEMENT OF GAUCHER DISEASE WHILE EMPHASIZING THE PIVOTAL ROLE OF THE INTERPROFESSIONAL TEAM IN COLLABORATING AND DELIVERING WELL-COORDINATED CARE TO IMPROVE PATIENT OUTCOMES.